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Purpose: To investigate possible neuronal dysfunction of the thalamus in patients
suffering from typical absence epilepsy, using magnetic resonance spectroscopy
(MRS). Special attention was paid to levels of N-acetylaspartate (NAA) and creatine
(Cr), and to the NAA/Cr ratio.
Methods: MRS was performed over the right and left thalamus in nine patients
suffering from typical absence epilepsy, and in nine sex- and age-matched healthy
controls. All patients and controls were examined using a standard MRS-CSI (chemical
shift imaging) technique.
Results: Statistical analysis of the obtained data demonstrated a significantly lower
thalamic NAA/Cr ratio in patients with typical absence epilepsy when compared to the
healthy controls. Our MRS data showed symmetrical distribution of NAA/Cr ratio in the
right and left thalamus within both the patient group and the group of healthy
controls. No significant correlation between the patients’ thalamic NAA/Cr values and
the duration of the epilepsy or seizure frequency was revealed.
Conclusions: The present MRS data clearly indicate neuronal dysfunction in the
thalami of patients with typical absence epilepsy. In agreement with other recent
MRS findings in different idiopathic generalized epilepsy syndromes, our results
confirm the role of the thalamus as an important structure in the pathogenesis of
typical absence epilepsy.
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Absences are generalized non-convulsive seizures.
They differ in many respects from other forms of
epileptic seizures.1—3 The International Classifica-
tion of Epilepsies (1989) recognized the heteroge-
neity of epilepsies with absence seizures, and
proposed the categorization of three syndromes
of idiopathic generalized epilepsy (IGE) with
absence seizures: childhood absence epilepsy, juve-
nile absence epilepsy, and juvenile myoclonic epi-
lepsy.4
Generalized absence seizures may be defined as
a paroxysmal loss of consciousness of sudden onset
and sudden end that is associated with recorded
bursts of bilaterally synchronous spike-and-wave
discharges in the electroencephalogram (EEG).5
Absence seizures may be typical or atypical. The
differentiation of these two types is principally
based on EEG findings.6 Clinically, there is normal
neurological status and normal psychomotor
development in patients with typical absence epi-
lepsy.
The pathophysiological mechanisms of absence
seizures have been studied in various animal mod-
els.7,8 From an ethical point of view, systematic
invasive EEG recording simply is not indicated in
patients with typical absence epilepsy, and there-
fore the pathophysiological mechanisms of absences
in humans remain poorly understood. Nevertheless,
some studies have proven that the major structures
that participate in the pathogenesis of typical
absence seizures are the thalamus and the cortex,
in particular the parietal and frontal areas.8—10 It
has been suggested that the generalized spike-and-
wave discharges are generated and sustained by
abnormal oscillatory rhythms in a thalamo-cortical
circuit that mainly involves the reticular thalamic
nucleus, thalamic relay neurons, and neocortical
pyramidal cells. Neither the cortex nor the thalamus
alone can probably sustain these discharges, which
may indicate that both structures together are
involved in their genesis.6,8
Magnetic resonance spectroscopy (MRS) is a non-
invasive imaging technique providing metabolic
information from different body tissues, including
the human brain.12—16 MRS is able to detect meta-
bolic abnormalities that are invisible to conven-
tional MRI, because these abnormalities may
precede structural changes.15 Conventional MRI
and MRS rely on the same physical principles to
collect the MR signal, but differ in the way the data
is processed, displayed, and interpreted. Instead
of images, as with MRI, data presented as a plot
with peak amplitudes compared with a respective
frequency is obtained with MRS.12,13,15 Variousmetabolites are detected in the spectrum. Three
major peaks characterize long-echo time 1H MRS
spectra: N-acetylaspartate (NAA) — marker of neu-
ronal and axonal viability and density; creatine (Cr)
— used as internal reference, since it is the most
stable cerebral metabolite; choline — reflecting
cellular proliferation. There are two types of MRS
techniques — single voxel and multivoxel. The mul-
tivoxel technique allows a number of voxels to be
positioned in the brain, enabling the simultaneous
investigation of the metabolic abnormalities in
many small volume units within the structure, and
shows the extension ofmetabolic abnormalities. It is
also referred to as ‘‘chemical shift imaging’’.16
The present research study was conducted to
investigate the potential involvement of thalamic
structures in the genesis of typical absence sei-
zures. We hypothesized that the concentration of
thalamic NAA might be lower in patients with typi-
cal absence epilepsy than in healthy control sub-
jects.Subjects and methods
Subjects
Nine epileptic patients (six females, threemales; all
right handed) suffering from typical absence epi-
lepsy were admitted to the study. The patients were
selected from the database of patients referred to
the regional epilepsy centre. The control group
consisted of nine sex (six females, three males)
and age matched healthy volunteers. The mean
age of the subjects in the patient group was
32.3  6.63 years (ages ranged from 25 to 43 years;
median age of 33 years); the mean age in the control
group was 27.6  3.70 years (ages ranged from 24 to
35 years; median age of 27 years). Patients did not
differ significantly in age distribution from the
healthy controls. We reviewed all video EEG records
from 1997 to 2002, and selected nine subjects who
fulfilled the diagnostic criteria for typical absence
epilepsy. Clinical data were prospectively obtained
from these subjects through careful interviews with
the patients and their family members, and by
reviewing hospital charts. In all of the investigated
patients, the typical absence epilepsy diagnosis was
based on a consonance of history data, ictal (bilat-
eral spike-and-wave activity in all patients) and
interictal EEG findings, ictal semiology, and negative
neuroimaging. Most of the patients had either
childhood or teenage seizure onset (two cited
seizure onset at 20 years of age). The mean age
of the patients at the time of seizure onset was
13.11  4.09 years; with a median age of 14 years.
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including long-term video-EEGmonitoring, high reso-
lution MRI, and neuropsychological testing. Neither
initial insult nor neuropsychological deficits were
revealed in our patients. According to history data
(seizure diary), the seizure frequency ranged from 1
to90 seizurespermonth,withameanof16.8  27.73
seizures per month. The interval between the most
recent seizure and the MRS investigation varied from
1 to 365 days,median 10.0. Following adjustments to
their pharmacotherapy, two patients had been sei-
zure free for 1 year at the time of MRS investigation.
The patients at the time of MRS investigationwere on
various pharmacotherapy programs: monotherapy of
sodium valproate (four patients); a combination of
sodium valproate and lamotrigine (two patients); a
combination of lamotrigine and ethosuximide (one
patient); a combination of sodium valproate, lamo-
trigine and carbamazepine (one patient); primidone,
lamotrigine, sodium valproate with clonazepam (one
patient).
The majority of the healthy subjects in the con-
trol group were volunteers from the professional
sector with no history of neurological or psychiatric
diseases. Informed consent was obtained from each
participant after all of the procedures were fully
explained, and the study received the approval of
the local ethics committee.Figure 1 Proton magnetic resonance spectroscopy (MRS) of t
Placement of the volume of interest over the right and left th
the voxels.MRS measurement
MR examinations were carried out on a 1.5 T Sie-
mens Symphony scanner (Erlangen, Germany)
equipped with a Numaris 4 System. After the estab-
lishment of the localizer, high-resolution anatomical
T1-weighted images in the sagittal planes, and T2-
weighted images in the coronal and transversal
planes, were obtained. Transversal MRI images were
acquired by using a turbo spin echo sequence with
the basic parameters TE = 90 ms and TR = 3170 ms.
These conventional MRI images served as a matrix
for the spectroscopic measurement, and served to
position a spectroscopic volume of interest (VOI).
Positioning of VOI was adjusted to the individual
anatomy on MRI images covering the right and the
left thalamus (Fig. 1). The proton spectroscopic
data were subsequently acquired by using a chemi-
cal shift imaging method with the basic parameters:
TR = 1360 ms; TE = 80 ms; number of scans = 12; flip
angle 908; FOV (field of view) 80 mm  80 mm;
VOI = 40 mm  40 mm; slice thickness = 10 mm;
8  8 phase-encodes (interpolated on 16  16); vec-
tor size = 1024 points; SW (bandwidth) = 1000 Hz.
Reduced sampling was used for elliptically scanning
the data. The water signal was suppressed to
acquire an adequate visualisation of the peaks of
the metabolites. The nominal voxel size in-planehe thalamus. T2-weighted image in the transversal plane.
alami; multi-voxel spectroscopy technique; positioning of
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Figure 2 The multivoxel spectroscopy metabolite map for N-acetylaspartate (NAA). Graphic demonstration of
selecting voxels with NAA concentration. Data are obtained from four adjacent voxels.was 10 mm  10 mm  10 mm; the final voxel size
in-plane was 5 mm  5 mm  10 mm.
The spectra were post-processed using software
supplied by the scanner producer. After post-pro-
cessing water suppression, zero-filling, baseline cor-
rection and phase correction, we determined peak
areas by integrating the corresponding signals fromFigure 3 Sample of spectra from the healthy control (A
metabolites.N-acetylaspartate (NAA) at 2.0 ppm (parts per mil-
lion), and creatine (Cr) at 3.0 ppm.
Using chemical shift imaging, we obtained two-
dimensional data sets. The spectral mapping that
enabled a spatial distribution of NAA and Cr con-
centration was used to analyze the spectroscopic
data (Fig. 2).) and the patient (B) depicting the values of analysed
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obtained from a spectral curve present in each small
voxel located in the thalamus (Fig. 3). The data of
NAA and Cr concentration were distributed in a
spectral map. Each analysed voxel was located
entirely within the thalamus, to minimize any meta-
bolic contamination from adjacent cerebrospinal
fluid or grey and white matter outside the thalamus.
Data for statistical analysis were obtained from
four adjacent voxels situated in the centre of the
right and left thalamus. AUC (area under the curve,
e.g. integral) values of NAA and Cr concentration
from these selected voxels were analysed as a ratio
of NAA to Cr.
Ratios of NAA/Cr of the determined voxels were
compared between both groups. At first, a compar-
ison of data from right and left thalami (right versus
right and left versus left) between the patients and
the healthy controls was performed. Subsequently,
the data from the voxels of both thalami (72 voxels)
of the patients and healthy controls were compared.
Statistical analysis
Group differences for age were tested by t-test.
To evaluate the differences of the NAA/Cr ratio in
the determined voxels, a two-way ANOVA test was
performed to compare the patients and the healthy
controls and to contrast the right and left thalamus
in patients and healthy controls. Statistical signifi-
cance was considered to be present if p < 0.05 in
tested parameters.
The Pearson correlation was computed between
spectroscopic data and the duration of epilepsy in
the patient group. The same approach was used to
study the hypothetical relationship between seizure
frequency and the values of NAA/Cr ratio.
The Statistica program from StatSoft was used.Results
Patients and healthy controls did not differ with
respect to age (patient group with a mean age of
32.3 years, S.D. = 6.63 years; healthy controls with a
mean age of 27.6 years, S.D. = 3.70; p = 0.084).
We performed a statistical comparison of the
metabolic NAA/Cr ratio between patients and
healthy controls and between the right and left
thalamus with an ANOVA test. A statistically signifi-
cant difference was found between the patients and
the control group, with lower values of the NAA/Cr
ratio in the typical absence epilepsy patients
( p = 0.000066, F(1;140) = 16.92).
When comparing the symmetry of the analysed
parameter distribution between the right and leftthalami, the ANOVA test showed no significant dif-
ferences in the mean thalamic NAA/Cr ratio in our
normal controls; nor were lateralised abnormalities
found in our typical absence epilepsy patients
(p = 0.127, F(1;140) = 2.36).
No significant interactions between our para-
meters were observed (p = 0.591, F(1;140) = 0.29).
In our data, no significant correlation between
the thalamic NAA/Cr ratio and the epilepsy duration
was observed (r = 0.15, p = 0.20). There was also
no correlation found between the level of NAA/Cr
ratio and seizure frequency (r = 0.20, p = 0.09).Discussion
Since typical absence epilepsies have moderate or
normal neurological status and behaviour, it is likely
that these disorders will have discrete brain altera-
tions that are not easy to detect by neuroimaging
techniques. Proton magnetic resonance spectro-
scopy might be extremely useful in the assessment
of this type of epilepsy, because of its ability to
accurately demonstrate focal functional impair-
ment in subjects when conventional MRI results
are negative.
Our analysis of spectroscopic images acquired
with the multivoxel proton MRS technique revealed
a significant reduction in the thalamic NAA/Cr ratio
in our group of patients with typical absence epi-
lepsy.
The spectral abnormalities found in our experi-
ment in patients with typical absence epilepsy
clearly extend beyond negative neuroimaging find-
ings. Negative MRI findings were also revealed in our
patients. In general, no structural lesion of any kind
has ever been identified as the substrate of typical
absence epilepsies.3,17
N-Acetylaspartate is present in the vertebrate
brain, where its concentration is one of the highest
of all free amino acids. Its prominence in MRS studies
has led to its wide use as a neuronal marker in
diagnostic human medicine, as an indicator both of
brain pathology and of disease progression in the
central nervous system. The NAA, when present in
the brain, appears to reflect a high degree of cellular
integration, and therefore may be a unique meta-
bolic construct of the intact vertebrate brain. It is
believed that a reduction in NAA and/or NAA/Cr ratio
indicates neuronal and/or axonal loss, loss of neuron
viability, and dysfunction.18—21 It should be recog-
nized that the macroscopic concentration of NAA
depends on the fluxes of synthetic and degradation
pathways, cellular density and brain water content
and distribution. Whether the reduction represents
an irreversible loss of cells or a potentially reversible
538 D. Fojtikova´ et al.metabolic process cannot readily be determined.
Nevertheless, our results, by showing metabolite
signal changes, detect some pathological processes
surpassing the structural changes.
Due to technical obstacles, we were unable to
statistically analyse the absolute values of respective
metabolites (e.g. NAA). Instead, the relative values
(ratios) were used. The quantification of NAA in
relation to Cr (NAA/Cr ratio) is widely and reasonably
used in various clinical and experimental set-
tings.21,22 Observations and studies using this
approach suppose that Cr is a stable internal refer-
ence. It is believed that relative signal intensities
provide an adequate basis for interpretation of the
results and that these intensities are sensitive to
neurochemical changes in cell population without
regard to absolute metabolite values. As the loss of
NAA may be in some cases accompanied by an
increase of Cr signal, the NAA/Cr ratios may show
the higher relative value, rather than an absolute
value in any individual signal.23However it is assumed
that Cr is relatively homogenously distributed
throughout the brain and is not significantly influ-
encedby theepileptic state.24 It is for this reason that
we justified the use of relative values as the markers
of changes in cell population in our study.
In the pathophysiological mechanism of absence
seizures, thalamocortical and corticothalamic pro-
jections play important roles. The pathophysiology
of idiopathic generalized epilepsy syndromes is not
fully understood, but it is generally accepted that
typical absence seizures are the result of abnormal
oscillations between the thalamus and cerebral
cortex.7,8 The neurochemical changes underlying
typical absence epilepsy have not yet been fully
elucidated, but they are a sphere for active research
in both affected humans and in animal models.21
Both inhibitory and excitatory neurotransmissions
participate in the genesis and control of absence
seizures. Whether the generation of spike-and-wave
discharges (SWDs) is the result of an excessive cor-
tical hyperexcitability, as was proposed in feline
generalized epilepsy,10,25 or an excessive thalamic
synchronization, possibly under the control of inhi-
bitory GABAergic mechanisms,26—28 remains contro-
versial. It appears that neurons, mainly involved in
the thalamic reticular nucleus (nRt),29 thalamic
relay neurons (RNs), and neocortical pyramidal cells
comprise a circuit that sustains the thalamocortical
oscillatory burst firing of absence seizures.7
Two main hypotheses have been proposed to
explain the pathogenesis of absence seizures in ani-
malmodels: either (1) excessive thalamic oscillations
due to hypersynchronization and/or (2) cortical
hyperexcitability, which may amplify physiological
rhythmic oscillations originating in the thalamus.Such dysfunctions may result from alterations
affecting: (1) synaptic communications within the
thalamo-cortical network; (2) intrinsic properties in
cortical and/or thalamic neurons; or (3) morpholo-
gical abnormalities within the thalamo-cortical cir-
cuit.8
According to some investigators, the cortex
seems to play a leading role. The corticothalamic
interrelationships were investigated by means of
nonlinear association signal analyses of multiple
spike-wave discharges. This showed a consistent
focus within the perioral region of the somatosen-
sory cortex. From this focus, seizure activity gen-
eralizes rapidly over the cortex. During the first
cycles of the seizure, the cortex drives the thala-
mus; thereafter the cortex and thalamus drive each
other, thus amplifying and maintaining the rhythmic
discharge. In this way the ‘‘cortical focus’’ theory
for generalized absence epilepsy bridges cortical
and thalamic theories.30
The idea that the neuronal elements of the tha-
lamocortical loop are crucial to the full expression of
SWDs is supported by single-photon emission tomo-
graphy study in children with childhood absence
epilepsy, which reveal hypermetabolism in cortical
and thalamic areas during absence seizures.31
To examine cortico-thalamic relationships during
the generation of SWDs, various cortical and thala-
mic areas were lesioned in GAERS (Genetic Absence
Epilepsy Rats from Strasbourg). The results of these
studies demonstrated that SWDs cannot occur in a
thalamus that is disconnected from the cortex, and
clearly showed that SWDs cannot occur in a cortex
deprived of its thalamic input.10,25,32
In our study, we presented a significantly lower
thalamic NAA/Cr ratio in the patient group than in
the healthy control group. The focus of this research
did not involve the investigation of adjacent areas
or other regions of the brain; nevertheless, an
analogous study in patients with juvenile myoclonic
epilepsy and generalized tonic clonic seizures on
awakening did not report any abnormal concentra-
tion of NAA/Cr in the insular cortex, posterior tem-
poral lobe white matter, or splenium of the corpus
callosum).21
A single voxel MRS study showed abnormally low
NAA/Cr levels in at least one thalamus in nine out of
ten patients with juvenile myoclonic epilepsy (JME),
indicating a neuronal dysfunction of the thalamus in
this IGE syndrome.22 In another single voxel study,
significant thalamic reduction of NAA was observed
in patients with pure primarily generalized tonic
clonic epilepsy in comparison with controls.33 A
recently published study, where authors used proton
magnetic resonance spectroscopic imaging, proved
a reduction of mean thalamic NAA/Cr in patients
MRS of the thalamus in typical absence epilepsy 539with IGE in comparison to normal controls.21 These
results are in agreement with our investigation; and
our MRS findings are in congruencewith previous and
recent theories that the thalamus plays an impor-
tant role in the pathophysiology of typical absence
epilepsy as has been proven in several subtypes of
IGE. To the best of our knowledge, the role of the
thalamus in other types of epilepsies (i.e. focal
epilepsies) has not yet been clarified.21,22,33
Bernasconi et al.,21 who studied NAA/Cr ratio in
idiopathic generalized epilepsy patients, found a
negative correlation between thalamic NAA/Cr
and the duration of epilepsy. There was no differ-
ence in NAA/Cr between the patients whose sei-
zures were well controlled and patients in whom
seizures were not controlled. In our present study,
there was neither a statistically significant correla-
tion between thalamic NAA/Cr ratio and the dura-
tion of epilepsy, nor a correlation with the seizure
frequency observed. Due to the small set of values,
the absence of correlation may be falsely negative.
Our results indicate a downward trend toward the
statistical significance in both tested parameters.
We can speculate that a statistical significance could
be reached with a wider range of values.
The generation of bilateraly generalized spike-
wave discharges is only possible in an anatomically
and functionally intact corticothalamic network
that is in a suitable state to propagate seizures.
The presence of abnormalities in the corticothala-
mic network has been suggested to be the functional
basis of absence seizure generation. Neuronal dys-
function in the thalamus has been indicated by MR
spectroscopy in several subtypes of IGE. However,
there is recent evidence of existing subcortical grey
and white matter volume reduction in childhood
absence epilepsy patients.34 Besides the metabolic
neuronal dysfunction, we can also assume a reduc-
tion of functional thalamic neurons (reflected by the
decrease of NAA), and the possibility of derange-
ment of thalamocortical glutamatergic and
intrathalamic GABAergic transmission that might
be caused by the mentioned reduction. In general,
themetabolite or structural changesmay be either a
result of damage from seizures or a reflection of
primary underlying pathology as the cause of
absence seizures. MRS studies in IGE suggest a key
role for the thalamus in the generation of prolonged
runs of generalized SWD, and support the concept of
thalamocortical circuit abnormalities as the under-
lying pathophysiological substrate of IGE.35 How-
ever the significant role of subcortical structures
and the pathophysiology of decreased NAA and other
metabolite or neurotransmitter disturbances in sei-
zure generation and propagation in idiopathic gen-
eralized epilepsy has not yet been elucidated.As far as we are aware, this is the first study
investigating neurochemical changes of the thala-
mus in typical absence epilepsy patients. Our
results, as well as the results of many other studies,
support the notion of a common pathophysiological
abnormality among different idiopathic generalized
epilepsy syndromes.
In conclusion, our presented findings are consis-
tent with the increasing evidence of an important
involvement of the thalamus, as a part of underlying
substrate, in the pathogenesis of absence seizures.
The possible alteration of neuronal pathways in the
thalamo-cortical circuit seems to play a critical role
in epileptogenesis of idiopathic generalized epilep-
sies, but has not, thus far, been confirmed, and
remains a topic for further studies in several world-
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